BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 12451130)

  • 1. Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat model of Parkinson's disease.
    Azzouz M; Martin-Rendon E; Barber RD; Mitrophanous KA; Carter EE; Rohll JB; Kingsman SM; Kingsman AJ; Mazarakis ND
    J Neurosci; 2002 Dec; 22(23):10302-12. PubMed ID: 12451130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease.
    Shen Y; Muramatsu SI; Ikeguchi K; Fujimoto KI; Fan DS; Ogawa M; Mizukami H; Urabe M; Kume A; Nagatsu I; Urano F; Suzuki T; Ichinose H; Nagatsu T; Monahan J; Nakano I; Ozawa K
    Hum Gene Ther; 2000 Jul; 11(11):1509-19. PubMed ID: 10945765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson's disease.
    Sun M; Kong L; Wang X; Holmes C; Gao Q; Zhang GR; Pfeilschifter J; Goldstein DS; Geller AI
    Hum Gene Ther; 2004 Dec; 15(12):1177-96. PubMed ID: 15684695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of aromatic L-amino acid decarboxylase for dopamine replacement by genetically modified fibroblasts in a rat model of Parkinson's disease.
    Wachtel SR; Bencsics C; Kang UJ
    J Neurochem; 1997 Nov; 69(5):2055-63. PubMed ID: 9349551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A site-specific mutation of tyrosine hydroxylase reduces feedback inhibition by dopamine in genetically modified cells grafted in parkinsonian rats.
    Chang JW; Lee WY; Milstien S; Kang UJ
    J Neurochem; 2002 Oct; 83(1):141-9. PubMed ID: 12358737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral recovery in 6-hydroxydopamine-lesioned rats by cotransduction of striatum with tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes using two separate adeno-associated virus vectors.
    Fan DS; Ogawa M; Fujimoto KI; Ikeguchi K; Ogasawara Y; Urabe M; Nishizawa M; Nakano I; Yoshida M; Nagatsu I; Ichinose H; Nagatsu T; Kurtzman GJ; Ozawa K
    Hum Gene Ther; 1998 Nov; 9(17):2527-35. PubMed ID: 9853519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease.
    Mandel RJ; Rendahl KG; Spratt SK; Snyder RO; Cohen LK; Leff SE
    J Neurosci; 1998 Jun; 18(11):4271-84. PubMed ID: 9592104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gene therapy of tyrosine hydroxylase, aromatic L-amino acid decarboxylase, and GTP cyclohydrolase genes in rat model of Parkinson's disease].
    Lu LL; Su Y; Duan CL; Zhao CL; Su YJ; Wu J; Zhao HY; Xu QY; Yang H
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(18):1528-32. PubMed ID: 15500713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes.
    Muramatsu S; Fujimoto K; Ikeguchi K; Shizuma N; Kawasaki K; Ono F; Shen Y; Wang L; Mizukami H; Kume A; Matsumura M; Nagatsu I; Urano F; Ichinose H; Nagatsu T; Terao K; Nakano I; Ozawa K
    Hum Gene Ther; 2002 Feb; 13(3):345-54. PubMed ID: 11860702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vector-mediated l-3,4-dihydroxyphenylalanine delivery reverses motor impairments in a primate model of Parkinson's disease.
    Rosenblad C; Li Q; Pioli EY; Dovero S; Antunes AS; Agúndez L; Bardelli M; Linden RM; Henckaerts E; Björklund A; Bezard E; Björklund T
    Brain; 2019 Aug; 142(8):2402-2416. PubMed ID: 31243443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent Expression of Dopamine-Synthesizing Enzymes 15 Years After Gene Transfer in a Primate Model of Parkinson's Disease.
    Sehara Y; Fujimoto KI; Ikeguchi K; Katakai Y; Ono F; Takino N; Ito M; Ozawa K; Muramatsu SI
    Hum Gene Ther Clin Dev; 2017 Jun; 28(2):74-79. PubMed ID: 28279081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adeno-associated virus vector-mediated triple gene transfer of dopamine synthetic enzymes.
    Fan D; Shen Y; Kang D; Nakano I; Ozawa K
    Chin Med J (Engl); 2001 Dec; 114(12):1276-9. PubMed ID: 11793852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cotransduction of tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes into cultured striatal cells using adeno-associated virus vectors.
    Fan D; Kang D; Ogawa M; Nakano I; Nagatsu T; Kurtzman GJ; Ozawa K
    Chin Med J (Engl); 1998 Dec; 111(12):1111-3. PubMed ID: 11263376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer.
    Georgievska B; Kirik D; Björklund A
    Exp Neurol; 2002 Oct; 177(2):461-74. PubMed ID: 12429192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term restoration of striatal L-aromatic amino acid decarboxylase activity using recombinant adeno-associated viral vector gene transfer in a rodent model of Parkinson's disease.
    Leff SE; Spratt SK; Snyder RO; Mandel RJ
    Neuroscience; 1999; 92(1):185-96. PubMed ID: 10392841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress in gene therapy for Parkinson's disease.
    Nakata Y; Yasuda T; Mochizuki H
    Curr Mol Med; 2012 Dec; 12(10):1311-8. PubMed ID: 22834832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and assessment of double genes of tyrosine hydroxylase gene and aromatic L-amino acid decarboxylase gene in vitro].
    Su Y; Duan CL; Zhao CL; Zhao HY; Xu QY; Yang H
    Sheng Li Xue Bao; 2003 Oct; 55(5):583-8. PubMed ID: 14566408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of a rat model of Parkinson's disease by coexpression of tyrosine hydroxylase and aromatic amino acid decarboxylase from a helper virus-free herpes simplex virus type 1 vector.
    Sun M; Zhang GR; Kong L; Holmes C; Wang X; Zhang W; Goldstein DS; Geller AI
    Hum Gene Ther; 2003 Mar; 14(5):415-24. PubMed ID: 12691607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholamines and Parkinson's disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overview.
    Nagatsu T
    J Neural Transm (Vienna); 2024 Jun; 131(6):617-630. PubMed ID: 37638996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adeno-associated virus-mediated gene transfer of human aromatic L-amino acid decarboxylase protects mixed striatal primary cultures from L-DOPA toxicity.
    Doroudchi MM; Liauw J; Heaton K; Zhen Z; Forsayeth JR
    J Neurochem; 2005 May; 93(3):634-40. PubMed ID: 15836622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.